World Solve

A subset of patients with chronic hives don't respond well to typical antihistamine treatment, leaving them with persistent, disruptive symptoms and few further options. More effective alternatives remain limited.

Childhood asthma rates have risen substantially, but why some children develop severe, persistent symptoms while others exposed to similar triggers don't remains only partly understood. A clearer answer could improve both prevention and treatment.

Many people who experience one episode of depression go on to experience another, and current treatments don't reliably prevent this recurrence. Better long-term prevention strategies remain an important gap in mental health care.

Stomach cancer often causes no clear symptoms until it has progressed significantly, particularly in regions without routine screening programs. Earlier, more accessible detection could substantially improve survival outcomes.

Osteoarthritis treatment currently focuses on managing pain and preserving remaining function rather than restoring lost cartilage. A regenerative treatment could transform care for one of the most common causes of chronic pain in older adults.

Thousands of patients remain on transplant waiting lists that never resolve in time, largely because donor organ supply can't keep pace with demand. Alternatives like lab-grown organs remain the most promising but still unrealized solution.

Repeated gout attacks can cause lasting joint damage even with treatment, and prevention still relies mainly on managing uric acid levels rather than fully eliminating the underlying risk. A more definitive prevention method remains unmet.

Narcolepsy causes sudden, uncontrollable sleep episodes that significantly disrupt daily life, and current treatments manage symptoms rather than address the underlying cause. A true cure remains undiscovered.

This parasitic disease affects millions in tropical and subtropical regions, but effective treatment remains expensive, difficult to access, or logistically challenging for many affected communities. Closing this access gap remains unresolved.

This rare but severe condition can develop rapidly after childbirth, and delays in recognition and treatment can have dangerous consequences for both mother and baby. Faster, more reliable detection and treatment protocols remain an urgent unmet need.

Malnutrition rates spike dramatically in areas affected by war, but delivering treatment consistently in unstable, hard-to-reach regions remains a persistent logistical and medical challenge. Solving this requires both medical and access innovation.

Persistent dizziness and balance problems can severely affect quality of life, yet treatment for many chronic cases remains limited and inconsistent. A more reliable, targeted treatment approach remains undeveloped.

Even with strict sterile procedures, a portion of surgical patients still develop infections afterward, extending recovery and sometimes causing serious complications. Reducing this risk further remains an ongoing surgical challenge.

Highly effective hepatitis C treatments exist, but cost and healthcare access still prevent many infected people worldwide from receiving them. Expanding affordable access remains the primary barrier rather than the science itself.

Diagnosing Alzheimer's currently often requires expensive brain imaging or invasive procedures, limiting how widely early detection can be used. A cheap, accessible blood test could change how early treatment can begin.

COPD gradually reduces lung function over years, and while treatment can ease symptoms and slow decline, it can't reverse the underlying lung damage. A cure remains out of reach for the millions living with this condition.

Cervical cancer remains highly preventable through regular screening, but many women in lower-resource regions lack consistent access to the tests that catch it early. Closing this access gap could prevent large numbers of otherwise preventable deaths.

Many people with chronic insomnia end up relying on sleep medication for years, since non-drug treatments don't work consistently for everyone. A more effective, sustainable solution remains an open need.

Even with modern reproductive technology, a significant share of infertility cases have no clear cause and don't respond well to existing treatments. Understanding these unexplained cases remains a major gap in reproductive medicine.

Effective vaccines exist for a small number of sexually transmitted infections, but many common ones still have no vaccine available at all. Expanding vaccine coverage here could significantly reduce global disease burden.